Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
00:01:07 EDT Tue 05 May 2026
Enter Symbol
or Name
USA
CA



Q:CRMD - CORMEDIX INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CRMD - Q0.57.68·7.910.27.90+0.111.41,100.18,1858,0587.75  8.04  7.620117.43  6.12519:38:17Apr 2715 min RT 2¢

Recent Trades - Last 10 of 8058
Time ETExPriceChangeVolume
19:38:17Q7.89810.1081500
19:34:15Q7.900.111
19:33:43Q7.860.07126
19:27:56Q7.84050.05058
19:17:32Q7.910.1289
19:00:29Q7.900.111
17:54:40Q7.930.147
17:46:31Q7.95390.1639500
17:40:43Q7.960.1710
17:37:34Q7.960.1710

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-04-27 07:30U:CRMDNews ReleaseCorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO(TM) for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients
2026-04-07 08:30U:CRMDNews ReleaseCorMedix to Participate in Needham Virtual Healthcare Conference
2026-03-05 07:30U:CRMDNews ReleaseCorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
2026-03-02 08:30U:CRMDNews ReleaseCorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026
2026-02-12 08:30U:CRMDNews ReleaseCorMedix to Participate in Upcoming Investor Conferences
2026-02-02 08:30U:CRMDNews ReleaseCorMedix Therapeutics Announces Share Repurchase Program
2026-01-29 08:30U:CRMDNews ReleaseCorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026
2026-01-09 08:30U:CRMDNews ReleaseCorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
2026-01-08 08:05U:CRMDNews ReleaseCorMedix Therapeutics Announces Leadership and Board Updates
2026-01-08 08:00U:CRMDNews ReleaseCorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates
2025-12-18 08:00U:CRMDNews ReleaseCorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath
2025-11-12 16:05U:CRMDNews ReleaseTalphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
2025-11-12 11:01U:CRMDNews ReleaseStrong Earnings and Biotech Resilience Define the Midweek Momentum
2025-11-12 07:30U:CRMDNews ReleaseCorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance
2025-10-31 08:30U:CRMDNews ReleaseCorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025
2025-10-23 08:30U:CRMDNews ReleaseCorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath
2025-10-21 08:30U:CRMDNews ReleaseTalphera Announces the Appointment of Joe Todisco to Board of Directors
2025-10-20 07:30U:CRMDNews ReleaseCorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance
2025-09-29 08:30U:CRMDNews ReleaseCorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO
2025-09-08 08:30U:CRMDNews ReleaseTalphera Announces Private Placement Financing of up to $29 Million Priced At-the Market